Publications by authors named "Jutatip Kaewmalee"
Pharmaceuticals (Basel)
April 2021
Article Synopsis
- Experimentation showed that it effectively reduced dyslipidemia, liver enzyme levels, and insulin resistance without causing liver or kidney toxicity, outperforming the standard treatment lovastatin.
- The compound also influenced gene expressions related to lipid metabolism and reduced hepatic gluconeogenesis, suggesting its potential as a treatment for dyslipidemia and related metabolic conditions.
